RESUMEN
BACKGROUND: Veno-arterial carbon dioxide tension difference (ΔPCO2) and mixed venous oxygen saturation (SvO2) have been shown to be markers of the adequacy between cardiac output and metabolic needs in critical care patients. However, they have hardly been assessed in trauma patients. We hypothesized that femoral ΔPCO2 (ΔPCO2 fem) and SvO2 (SvO2 fem) could predict the need for red blood cell (RBC) transfusion following severe trauma. METHODS: We conducted a prospective and observational study in a French level I trauma center. Patients admitted to the trauma room following severe trauma with an Injury Severity Score (ISS) > 15, who had arterial and venous femoral catheters inserted were included. ΔPCO2 fem, SvO2 fem and arterial blood lactate were measured over the first 24 h of admission. Their abilities to predict the transfusion of at least one pack of RBC (pRBCH6) or hemostatic procedure during the first six hours of admission were assessed using receiver operating characteristics curve. RESULTS: 59 trauma patients were included in the study. Median ISS was 26 (22-32). 28 patients (47%) received at least one pRBCH6 and 21 patients (35,6%) had a hemostatic procedure performed during the first six hours of admission. At admission, ΔPCO2 fem was 9.1 ± 6.0 mmHg, SvO2 fem 61.5 ± 21.6% and blood lactate was 2.7 ± 1.9 mmol/l. ΔPCO2 fem was significantly higher (11.6 ± 7.1 mmHg vs. 6.8 ± 3.7 mmHg, P = 0.003) and SvO2 fem was significantly lower (50 ± 23 mmHg vs. 71.8 ± 14.1 mmHg, P < 0.001) in patients who were transfused than in those who were not transfused. Best thresholds to predict pRBCH6 were 8.1 mmHg for ΔPCO2 fem and 63% for SvO2 fem. Best thresholds to predict the need for a hemostatic procedure were 5.9 mmHg for ΔPCO2 fem and 63% for SvO2 fem. Blood lactate was not predictive of pRBCH6 or the need for a hemostatic procedure. CONCLUSION: In severe trauma patients, ΔPCO2 fem and SvO2 fem at admission were predictive for the need of RBC transfusion and hemostatic procedures during the first six hours of management while admission lactate was not. ΔPCO2 fem and SvO2 fem appear thus to be more sensitive to blood loss than blood lactate in trauma patients, which might be of importance to early assess the adequation of tissue blood flow with metabolic needs.
Asunto(s)
Arteria Femoral , Vena Femoral , Hemorragia , Heridas y Lesiones , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis de los Gases de la Sangre , Dióxido de Carbono/sangre , Arteria Femoral/química , Vena Femoral/química , Hemorragia/sangre , Hemorragia/diagnóstico , Hemorragia/etiología , Hemorragia/terapia , Hemostáticos , Puntaje de Gravedad del Traumatismo , Ácido Láctico/sangre , Oxígeno/sangre , Estudios Prospectivos , Heridas y Lesiones/complicaciones , Valor Predictivo de las PruebasRESUMEN
Methadone is an opioid that often leads to fatalities. Interpretation of toxicological findings can be challenging if no further information about the case history is available. The aims of this study were (1) to determine whether brain/blood ratios can assist in the interpretation of methadone findings in fatalities; (2) to examine whether polymorphisms in the gene encoding the P-glycoprotein (also known as multidrug resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1)), which functions as a multispecific efflux pump in the blood-brain barrier, affect brain/blood ratios of methadone. Femoral venous blood and brain tissue (medulla oblongata and cerebellum) from 107 methadone-related deaths were analysed for methadone by gas chromatography-mass spectrometry. In addition, all the samples were genotyped for three common ABCB1 single nucleotide polymorphisms (SNPs rs1045642, rs1128503, and rs2032582) using ion-pair reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry (ICEMS). In nearly all cases, methadone concentrations were higher in the brain than in the blood. Inter-individual brain/blood ratios varied (0.6-11.6); the mean ratio was 2.85 (standard deviation 1.83, median 2.35). Moreover, significant differences in mean brain/blood ratios were detected among the synonymous genotypes of rs1045642 in ABCB1 (p = 0.001). Cases with the T/T genotype had significantly higher brain/blood ratios than cases with the other genotypes (T/T vs. T/C difference (d) = 1.54, 95% CI [1.14, 2.05], p = 0.002; T/T vs. C/C d = 1.60, 95% CI [1.13, 2.29], p = 0.004). Our results suggest that the rs1045642 polymorphisms in ABCB1 may affect methadone concentrations in the brain and its site of action and may be an additional factor influencing methadone toxicity.
Asunto(s)
Cerebelo/química , Vena Femoral/química , Genotipo , Bulbo Raquídeo/química , Metadona/análisis , Polimorfismo de Nucleótido Simple , Subfamilia B de Transportador de Casetes de Unión a ATP/genética , Adulto , Análisis Químico de la Sangre , Barrera Hematoencefálica/metabolismo , Cromatografía Líquida de Alta Presión , Femenino , Toxicología Forense/métodos , Cromatografía de Gases y Espectrometría de Masas , Humanos , Masculino , Persona de Mediana Edad , Espectrometría de Masa por Ionización de ElectrosprayRESUMEN
BACKGROUND/AIMS: Sphingosine-1-phosphate (S1P) is a bioactive lysosphingolipid that is found in high concentration in plasma. The majority of plasma S1P is transported bound to HDL and albumin. Although the major sources of circulating S1P have been identified, it remains obscure what is the contribution of different organs/tissues to S1P homeostasis in plasma. Answering this question was the major aim of the present study. METHODS: The experiment was performed on male Wistar rats from whom blood samples were taken from either: 1) femoral vein, right ventricle of the heart, and abdominal aorta (n=15) or 2) hepatic vein, portal vein, and abdominal aorta (n=11). Plasma was fractionated by sequential flotation ultracentrifugation and sphingolipids were quantified by a HPLC method. RESULTS: Compared to the mixed venous blood sampled from the right ventricle, total plasma and lipoprotein-depleted plasma (LPDP) concentration of S1P in the arterial blood was lower. On the other hand, the level of S1P increased across the leg both in plasma and LPDP. The concentration of S1P, sphingosine, and sphinganine in the plasma, HDL, and LPDP isolated from the blood taken from the hepatic vein was markedly higher compared to both arterial and portal blood. CONCLUSIONS: We conclude that, in contrast to HDL-bound S1P, albumin-associated S1P is very labile in the circulation. It is degraded in the pulmonary, and to a lesser extent, gastrointestinal circulation, and released across the liver and skeletal muscle. We also conclude that liver is an important source of HDL-bound S1P and circulating free sphingoid bases.
Asunto(s)
Cromatografía Líquida de Alta Presión , Lisofosfolípidos/sangre , Esfingosina/análogos & derivados , Animales , Aorta Abdominal/química , Aorta Abdominal/metabolismo , Vena Femoral/química , Vena Femoral/metabolismo , Ventrículos Cardíacos/química , Ventrículos Cardíacos/metabolismo , Venas Hepáticas/química , Venas Hepáticas/metabolismo , Lipoproteínas HDL/química , Lipoproteínas HDL/metabolismo , Lipoproteínas LDL/química , Lipoproteínas LDL/metabolismo , Masculino , Vena Porta/química , Vena Porta/metabolismo , Unión Proteica , Ratas , Ratas Wistar , Esfingolípidos/sangre , Esfingolípidos/química , Esfingolípidos/metabolismo , Esfingosina/sangreRESUMEN
Postmortem redistribution (PMR) concerns blood drug concentration variations after death, depending on many factors such as sampling site and technique. In our study, we focused on sampling method. 30 cases were sampled, each at cardiac, subclavian, femoral, and popliteal sites. Targeted substances were diazepam, methadone, and morphine. Blind stick and dissection/clamping techniques were concomitantly performed at subclavian and femoral sites. Subclavian and femoral concentrations were compared according to technique used. To assess the influence of sampling technique on PMR, central/peripheral ratios were calculated depending on sampling method. Results show that drug concentrations tend to be lower when drawn from a clamped subclavian or femoral vein whereas ratios including subclavian and/or femoral blood concentration are influenced according to the technique used. In conclusion, clamping a subclavian or femoral vessel before sampling tends to result in lower drug concentrations and may influence ratios, suggesting the importance of isolating vessels from thoraco-abdominal viscera.
Asunto(s)
Diazepam/farmacocinética , Vena Femoral/química , Metadona/farmacocinética , Morfina/farmacocinética , Cambios Post Mortem , Constricción , HumanosRESUMEN
The aims of this study were to check whether different biomarkers of inflammatory, apoptotic, immunological or lipid pathways had altered their expression in the occluded popliteal artery (OPA) compared with the internal mammary artery (IMA) and femoral vein (FV) and to examine whether glycemic control influenced the expression of these genes. The study included 20 patients with advanced atherosclerosis and type 2 diabetes mellitus, 15 of whom had peripheral arterial occlusive disease (PAOD), from whom samples of OPA and FV were collected. PAOD patients were classified based on their HbA1c as well (HbA1c ≤ 6.5) or poorly (HbA1c > 6.5) controlled patients. Controls for arteries without atherosclerosis comprised 5 IMA from patients with ischemic cardiomyopathy (ICM). mRNA, protein expression and histological studies were analyzed in IMA, OPA and FV. After analyzing 46 genes, OPA showed higher expression levels than IMA or FV for genes involved in thrombosis (F3), apoptosis (MMP2, MMP9, TIMP1 and TIM3), lipid metabolism (LRP1 and NDUFA), immune response (TLR2) and monocytes adhesion (CD83). Remarkably, MMP-9 expression was lower in OPA from well-controlled patients. In FV from diabetic patients with HbA1c ≤6.5, gene expression levels of BCL2, CDKN1A, COX2, NDUFA and SREBP2 were higher than in FV from those with HbA1c >6.5. The atherosclerotic process in OPA from diabetic patients was associated with high expression levels of inflammatory, lipid metabolism and apoptotic biomarkers. The degree of glycemic control was associated with gene expression markers of apoptosis, lipid metabolism and antioxidants in FV. However, the effect of glycemic control on pro-atherosclerotic gene expression was very low in arteries with established atherosclerosis.
Asunto(s)
Arteriopatías Oclusivas/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Vena Femoral/química , Enfermedad Arterial Periférica/metabolismo , Arteria Poplítea/química , Anciano , Anciano de 80 o más Años , Arteriopatías Oclusivas/sangre , Arteriopatías Oclusivas/diagnóstico , Arteriopatías Oclusivas/genética , Biomarcadores/análisis , Biomarcadores/sangre , Biopsia , Constricción Patológica , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/genética , Femenino , Vena Femoral/efectos de los fármacos , Regulación de la Expresión Génica , Marcadores Genéticos , Hemoglobina Glucada/análisis , Humanos , Hipoglucemiantes/uso terapéutico , Mediadores de Inflamación/análisis , Modelos Lineales , Masculino , Arterias Mamarias/química , Persona de Mediana Edad , Análisis Multivariante , Enfermedad Arterial Periférica/sangre , Enfermedad Arterial Periférica/diagnóstico , Enfermedad Arterial Periférica/genética , Arteria Poplítea/efectos de los fármacos , ARN Mensajero/análisis , EspañaRESUMEN
Contrast-enhanced ultrasound has shown significant promise as a molecular imaging modality. However, one potential drawback is the difficulty that ultrasound contrast agents (UCA) may have in achieving adhesion to target molecules on the vascular endothelium. Microbubble UCA exhibit a lateral migration toward the vessel axis in laminar flow, preventing UCA contact with the endothelium. In the current study, we have investigated low-amplitude acoustic radiation as a mechanism to move circulating UCA toward targeted endothelium. Intravital microscopy was used to assess the retention of microbubble UCA targeted to P-selectin in the mouse cremaster microcirculation and femoral vessels. Acoustic treatment enhanced UCA retention to P-selectin four-fold in cremaster venules and in the femoral vein and 20-fold in the femoral artery. These results suggest acoustic treatment as a mechanism for enabling ultrasound-based molecular imaging in blood vessels with hemodynamic and anatomical conditions otherwise adversarial for UCA retention.
Asunto(s)
Microburbujas , Ultrasonido , Músculos Abdominales/irrigación sanguínea , Animales , Adhesión Celular , Endotelio Vascular/química , Arteria Femoral/química , Vena Femoral/química , Fluorocarburos , Leucocitos/química , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microcirculación , Modelos Animales , Selectina-P , Tamaño de la Partícula , Ultrasonografía/métodosRESUMEN
Over the last 15 years, numerous deaths involving "Ecstasy" (3,4-methylenedioxymethamphetamine, MDMA) have been reported and described in the literature. In most cases, either antemortem or postmortem concentration data are available. Because of the wide range of results and potential idiosyncratic nature of MDMA toxicity, interpretation of both antemortem and postmortem concentrations is difficult. The possible influence of postmortem redistribution may be an overlooked factor, but existing data involve postmortem concentrations from varying anatomical sites. However, this paper describes for the first time an evaluation of the concentrations of MDMA and 3,4-methylenedioxyamphetamine (MDA) found in five fatalities admitted to hospital where both antemortem and postmortem blood samples were available. Admission MDMA and MDA concentrations ranged between 0.55 and 4.33 mg/L and 0 and 0.10 mg/L, respectively, in antemortem serum/plasma. Postmortem blood MDMA and MDA concentrations ranged between 0.47 and 28.39 mg/L and 0.02 and 1.33 mg/L, respectively. Postmortem concentrations were higher than corresponding antemortem concentrations in all 5 cases with postmortem/antemortem ratios between 1.1 and 6.6 for MDMA and 1.5 and 13.3 for MDA. Differences in concentrations were also observed between anatomical sites, with central sites (e.g., heart) having much higher concentrations than peripheral sites (e.g., femoral). Overall, MDMA and MDA appear to exhibit postmortem redistribution and concentrations measured in postmortem specimens (even from peripheral sites) are not directly comparable with antemortem findings close to or prior to death.
Asunto(s)
3,4-Metilenodioxianfetamina/farmacocinética , Alucinógenos/farmacocinética , N-Metil-3,4-metilenodioxianfetamina/farmacocinética , Cambios Post Mortem , 3,4-Metilenodioxianfetamina/sangre , 3,4-Metilenodioxianfetamina/envenenamiento , Adulto , Sobredosis de Droga , Femenino , Vena Femoral/química , Vena Femoral/metabolismo , Alucinógenos/sangre , Alucinógenos/envenenamiento , Humanos , Masculino , Persona de Mediana Edad , Miocardio/química , Miocardio/metabolismo , N-Metil-3,4-metilenodioxianfetamina/sangre , N-Metil-3,4-metilenodioxianfetamina/envenenamiento , Admisión del Paciente , Distribución Tisular , Cuerpo Vítreo/química , Cuerpo Vítreo/metabolismoRESUMEN
BACKGROUND: Clinical observation suggests that chronic venous insufficiency is related to failure of venous valves. Duplex ultrasound studies of lower extremity superficial veins regularly show valve failure and venous reflux. Gross morphologic observation of venous valves in surgical specimens shows tearing, splitting, scarring, and disappearance of valves. HYPOTHESIS: Venous valve damage is acquired, linked with venous hypertension, and affected by inflammation. OBJECTIVE: The objective of this study was to investigate the inflammatory process in valve remodeling associated with acute and chronic venous hypertension. METHODS: A femoral arteriovenous fistula was created in study animals (Wistar rats, n = 60), and animals without an arteriovenous fistula were studied as controls (n = 5). At 1, 7, 21, and 42 days animals with the femoral arteriovenous fistula were anesthetized, and systemic pressure, the pressure in the femoral vein distal to fistula, and the pressure of the femoral vein in the contralateral hind limb were measured. Timed collection of blood backflow after division of the femoral vein distal to the fistula and in the alive, anesthetized animal was collected, measured, and calculated per unit time to be used as an indicator of valve insufficiency. The femoral vein distal to the fistula was harvested; valvular structures were examined and measured. Specimens were processed, and longitudinal sections were made and challenged with immunostaining antibodies against matrix metalloprotease (MMP)-2 and MMP-9. Sections were examined, and expression of molecular markers was determined by light absorption measurements after image digitization. RESULTS: One week after the procedure, all animals exhibited some degree of hind limb edema ipsilateral to the arteriovenous fistula. Pressure in the femoral vein distal to the fistula was markedly increased on average to 96 +/- 9 mm Hg. Reflux was increased in a time-dependent manner, with the 21-day and 42-day groups showing the highest values. Valves just distal to the fistula showed an increased diameter of the valvular annulus and a shortening of the annular height. Venous wall findings included fibrosis and fusion of the media and adventitia and scarring and disappearance of valves principally in the 21- and 42-day specimens. Immunolabeling for MMP-2 showed an increased level in the 21- and 42-day groups. MMP-9 showed an increased level at 1 day, followed by a more marked level in the 21- and 42-day groups. CONCLUSIONS: In this animal model of venous hypertension the findings of limb edema, increasing valvular reflux, and morphologic changes of increased annulus diameter and valve height are seen. Histologic changes included massive fibrosis of media and fusion with adventitia. Inflammatory markers MMP-2 and MMP-9 are strongly represented, and valve disappearance occurs after these markers are present. The gross morphologic changes seen are quite similar to those observed in human surgical specimens removed in treatment of venous insufficiency. CLINICAL RELEVANCE: When observed angioscopically at the time of vein stripping, saphenous vein valves show severe deformities including shortening, scarring, and tearing. The current model of induced venous hypertension demonstrates early venous valve changes that replicate those observed in humans. This observation provides a link from venous hypertension to an induced inflammatory reaction that stimulates the valve damage. Thus the model could be useful for defining the fundamental mechanisms that cause venous valve failure and varicose veins and in pharmacologic testing to prevent or treat venous insufficiency.
Asunto(s)
Vena Femoral/inmunología , Inflamación/inmunología , Insuficiencia Venosa/inmunología , Presión Venosa , Animales , Vena Femoral/química , Vena Femoral/fisiopatología , Hemodinámica , Masculino , Metaloproteinasa 2 de la Matriz/análisis , Metaloproteinasa 2 de la Matriz/inmunología , Metaloproteinasa 9 de la Matriz/análisis , Metaloproteinasa 9 de la Matriz/inmunología , Modelos Animales , Ratas , Ratas Wistar , Insuficiencia Venosa/fisiopatologíaRESUMEN
The case history and toxicological findings of an overdose fatality involving 4-methylthioamphetamine (4-MTA) and 3,4-methylenedioxymethamphetamine (MDMA) are reported along with a description of the analytical method. Detection and quantitation of 4-MTA and MDMA were performed by liquid chromatography-tandem mass spectrometry using phentermine as internal standard. Application of this technique to a variety of matrices allowed an insight in the distribution of 4-MTA. Several blood samples including femoral vein blood (5.23 mg/L), urine (95.5 mg/L), vitreous humor (1.31 mg/L), bile (36.4 mg/L), and numerous tissue samples such as liver (30.8 mg/kg), spleen (4.10 mg/kg), and frontal lobe (31.7 mg/kg) were assayed. These values indicated that 4-MTA could be identified as the cause of this fatality, whereas the concentrations of MDMA, also described, are less important because the concentrations found are lower. This case reports, for the first time, an extensive toxicological analysis of 4-MTA, by which the data presented may shed some light on the distribution of 4-MTA.
Asunto(s)
Anfetaminas/envenenamiento , Sobredosis de Droga , Alucinógenos/envenenamiento , N-Metil-3,4-metilenodioxianfetamina/envenenamiento , Inhibidores Selectivos de la Recaptación de Serotonina/envenenamiento , Adulto , Anfetaminas/análisis , Anfetaminas/farmacocinética , Autopsia , Cromatografía Liquida , Resultado Fatal , Vena Femoral/química , Alucinógenos/análisis , Alucinógenos/farmacocinética , Humanos , Masculino , Espectrometría de Masas , N-Metil-3,4-metilenodioxianfetamina/análisis , N-Metil-3,4-metilenodioxianfetamina/farmacocinética , Inhibidores Selectivos de la Recaptación de Serotonina/análisis , Inhibidores Selectivos de la Recaptación de Serotonina/farmacocinética , Distribución Tisular , Cuerpo Vítreo/químicaRESUMEN
In the biosynthesis of adrenomedullin (AM), glycine-extended AM, an intermediate form (iAM) processed from proAM is converted to AM[1-52]-NH2, the bioactive mature form of AM (mAM), by enzymatic amidation. We earlier showed that both molecular forms of AM circulate in human plasma. In the present study, to investigate the secretion and clearance sites of mAM and iAM in humans, we examined the plasma mAM and iAM concentrations in the femoral artery and vein (FA and FV), the aortic root and coronary sinus (AO and CS), and the pulmonary artery and capillary (PA and PC) of patients with ischemic heart disease. Plasma mAM in FV was significantly (p<0.001) higher than in FA. There also was a significant (p<0.001) step-up in the plasma mAM of the CS as compared to the AO. In contrast, plasma mAM was significantly (p<0.001) reduced in the PC as compared to the PA. However, such differences were not observed in plasma iAM levels. These findings suggest that in humans the vasculature of the lower extremities and the heart produce and secrete mAM and that the lung is a clearance site of circulating mAM.
Asunto(s)
Péptidos/metabolismo , Procesamiento Proteico-Postraduccional , Adrenomedulina , Adulto , Anciano , Aorta/química , Capilares/química , Femenino , Arteria Femoral/química , Vena Femoral/química , Humanos , Pulmón/irrigación sanguínea , Pulmón/metabolismo , Masculino , Persona de Mediana Edad , Isquemia Miocárdica/sangre , Isquemia Miocárdica/metabolismo , Miocardio/química , Miocardio/patología , Péptidos/sangre , Precursores de Proteínas/sangre , Precursores de Proteínas/metabolismo , Arteria Pulmonar/químicaRESUMEN
PURPOSE: The aim of this study was to measure the distribution of endogenous plasminogen activators during thrombolysis with an endothelial-conserving model of laminated thrombosis. METHODS: Thrombi were raised in the inferior vena cava of rats with thrombin and flow reduction. The thrombi, adjacent vein wall, and distant veins (the superior vena cava) were removed at intervals from 1 hour to 21 days from formation and then cryohomogenized and assayed with specific bioimmunoassays for tissue-type (t-PA) and urokinase-type plasminogen activators (u-PA). RESULTS: The measured t-PA activity of the vein wall around the thrombus was reduced compared with the control inferior vena cava at 4 days. Both the u-PA and t-PA content of the thrombus increased progressively during thrombolysis. The t-PA activity increased significantly in the distant vein walls in the animals with thrombi. Immunocytochemistry and in situ hybridization localized the t-PA to a mononuclear cell infiltrate and showed up-regulation of mRNA for rat t-PA in these monocytes. CONCLUSIONS: The local plasminogen activator response was predominantly within the thrombus itself. Increased t-PA activity was additionally found in distant veins but was reduced in the vessel wall adjacent to the thrombus. This is the first report to show that u-PA activity is increased within organizing thrombus in vivo and that most of the t-PA activity is localized to a monocyte infiltrate.
Asunto(s)
Terapia Trombolítica , Trombosis/enzimología , Activador de Tejido Plasminógeno/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Vena Cava Inferior/enzimología , Animales , Modelos Animales de Enfermedad , Vena Femoral/química , Vena Femoral/enzimología , Inmunoensayo/métodos , Masculino , Ratas , Ratas Endogámicas , Trombosis/etiología , Trombosis/terapia , Factores de Tiempo , Activador de Tejido Plasminógeno/análisis , Activador de Plasminógeno de Tipo Uroquinasa/análisis , Vena Cava Inferior/química , Vena Cava Superior/química , Vena Cava Superior/enzimologíaRESUMEN
1. The concentrations of amiodarone/desethylamiodarone, digoxin, flecainide and sotalol were measured in serum collected immediately prior to death and in postmortem blood collected from the femoral vein and artery of an 18-year-old male with congenital heart disease who developed a fatal arrhythmia. 2. The concentrations of all four drugs in the sample collected during life were consistent with the dosage given and in the range accepted for normal therapy. 3. There were no differences in amiodarone/desethylamiodarone, flecainide and sotalol concentrations in arterial or venous postmortem blood. 4. The concentrations of desethylamiodarone, digoxin, flecainide and sotalol but not amiodarone, were higher in postmortem blood than in antemortem serum. The flecainide concentration was significantly greater than the upper limit associated with toxicity in life. Without knowledge of the true concentration measured in life, this apparently high, toxic concentration would have suggested that death could have resulted from arrhythmogenic/proarrhythmic effects of the drug in excess. 5. These results further demonstrate the hazards in interpreting postmortem blood concentrations following suspected drug intoxication.
Asunto(s)
Antiarrítmicos/sangre , Adolescente , Amiodarona/análogos & derivados , Amiodarona/sangre , Digoxina/sangre , Arteria Femoral/química , Vena Femoral/química , Flecainida/sangre , Humanos , Masculino , Cambios Post Mortem , Sotalol/sangreRESUMEN
A case investigated by the Office of the Chief Medical Examiner, State of Maryland, identified methadone at a heart blood concentration of 2.4 mg/L and a subclavian blood concentration of 0.8 mg/L. Due to these discrepant results, a study was undertaken to determine whether such inconsistencies occurred in other methadone cases. Of the 15 cases studied, only four had heart blood and alternate blood concentrations within 20% of one another. In only 53% of the cases were variations of < 60% observed. The data failed to show a trend where one site was consistently higher or lower than the other site.
Asunto(s)
Vasos Coronarios/química , Metadona/sangre , Adulto , Vena Femoral/química , Humanos , Masculino , Pericardio/química , Cambios Post Mortem , Vena Subclavia/química , Distribución Tisular , Venas/química , Vena Cava Inferior/químicaRESUMEN
We evaluated the compliance characteristics of autogenous vein grafts clinically and experimentally. The image analysis instrument was applied in measuring the relative contents of elastin and collagen of the grafts. The results showed the consistent compliance mismatch between the vein graft and the host artery, but no definitive bearing on abnormal blood flow velocity waveform by the compliance mismatch. The compliance characteristics of the vein graft resembled these of the vein rather than those of the artery. The relative contents of elastin and collagen within the graft wall and the ratio of collagen to elastin (C/E) did not change significantly as a function of time. The vein graft and vein had the similar value of C/E, which was lower than that of the artery.
Asunto(s)
Vena Safena/trasplante , Adolescente , Adulto , Animales , Fenómenos Biomecánicos , Arteria Braquial/cirugía , Niño , Colágeno/análisis , Adaptabilidad , Perros , Elastina/análisis , Femenino , Arteria Femoral/cirugía , Vena Femoral/química , Vena Femoral/trasplante , Humanos , Masculino , Persona de Mediana Edad , Arteria Poplítea/cirugía , Vena Safena/químicaRESUMEN
L-Arginine plays an important role in protecting animals against ammonia intoxication, enhances immune function, stimulates wound healing, and is the precursor for the endothelium-derived relaxing factor, recently recognized as nitric oxide (NO). In this study, we investigated the influence of hepatic reperfusion on amino acid metabolism after human OLT. After 10 sec of reperfusion, the arterial plasma levels of L-arginine dropped from 105 +/- 12 mumol/L to 3.8 +/- 0.6 mumol/L (P < 0.001), whereas plasma ornithine increased from 40 +/- 5.5 mumol/L to 129 +/- 15 mumol/L (P < 0.001). The reduced L-arginine levels remained subnormal for several hours after OLT. This drop in plasma L-arginine was due to an arginase release from the implanted graft. Immediately after reperfusion, the plasma concentrations of arginase increased from pretransplantation values of 18 +/- 13 IU/L to 2384 +/- 1456 IU/L (P < 0.01). Measurement of plasma nitrite (NO2-) and nitrate (NO3-), which are the stable end products of NO, revealed that NO2- decreased about 50% after reperfusion (from 1.64 +/- 0.32 mumol/L to 0.80 +/- 0.17 mumol/L; P < 0.001), whereas NO3- levels remained unchanged (76 +/- 23 mumol/L vs. 63 +/- 8 mumol/L). We conclude that hepatic reperfusion causes L-arginine deficiency by liberating high amounts of arginase from the implanted graft. This L-arginine depletion may influence the NO synthesis in patients after OLT.
Asunto(s)
Arginina/deficiencia , Trasplante de Hígado , Adulto , Arginasa/sangre , Arginasa/metabolismo , Arginina/sangre , Femenino , Vena Femoral/química , Humanos , Trasplante de Hígado/fisiología , Masculino , Persona de Mediana Edad , Óxido Nítrico/metabolismo , Arteria Radial/químicaRESUMEN
Several studies in the rat indicate that opioid peptides produced in the testicular interstitial compartment can affect events in the tubular compartment. For example, it is thought that some specific functions of Sertoli cells, such as androgen-binding protein production are decreased by a paracrine mechanism. In this study ACTH beta-endorphin and cortisol were measured in the femoral and spermatic venous blood drawn from 18 patients affected by varicocele during catheterization for venous occlusion. The results showed the absence of a significant secretory gradient of beta-endorphin in the human testis and also demonstrated that this opioid is circulating at picomolar concentrations within human testis under stress conditions.